Subscribe
Logo small
Search
banner

Prof. Monika Adamczyk-Sowa: MS drug program is a milestone, but some modifications needed

MedExpress Team

Piotr Wójcik

Published May 29, 2023 11:43

Prof. Monika Adamczyk-Sowa: MS drug program is a milestone, but some modifications needed - Header image
  • In Poland at the moment we have access to all the drugs that are currently registered in the world.
  • Patients with multiple sclerosis are young people. The disease will be with them for many years, so treatment needs to be p...

    Content locked

    To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

    If you already have an account, please log in

Similar articles

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also